News & Updates

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

New drug applications approved by US FDA as of 16-31 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

09 Apr 2025

Women are more likely than men to fill prescriptions for statin, particularly high-intensity dosages, after undergoing coronary artery bypass surgery (CABG), with statin therapy equally effective at reducing mortality for both sexes, according to a study.

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

09 Apr 2025

Heart failure precedes rapid, sustained cognitive decline

08 Apr 2025 by

A rapid and persistent deterioration in cognitive function appears to occur following the onset of heart failure (HF), as reported in a study.

Heart failure precedes rapid, sustained cognitive decline

08 Apr 2025

What’s new in the 2025 ACS Guidelines?

08 Apr 2025 by

The American College of Cardiology and the American Heart Association (ACC/AHA) have issued new guidelines for managing acute coronary syndromes (ACS), outlining strategies for lipid management, minimizing bleeding risk, and considerations related to procedural care.

What’s new in the 2025 ACS Guidelines?

08 Apr 2025

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

05 Apr 2025

Long-term use of over-the-counter magnesium supplements appears to have cardioprotective benefits in patients with diabetes, having been shown to reduce the risk of heart failure (HF) and major adverse cardiac events, according to a study.

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

05 Apr 2025

Original New Drug Application Approvals by US FDA (1-15 March 2025)

04 Apr 2025

New drug applications approved by US FDA as of 1-15 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2025)

04 Apr 2025

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

31 Mar 2025

The selective serotonin reuptake inhibitor fluoxetine appears to modify lipid profile in individuals with overweight or obesity, with triglyceride levels reduced and high-density lipoprotein cholesterol (HDL-C) levels increased, according to a systematic review and meta-analysis.

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

31 Mar 2025

OSA, anaemia show synergistic effect on hypertension

28 Mar 2025

Anaemia and obstructive sleep apnoea (OSA) appear to have a combined impact on the incidence of hypertension, suggests a study.

OSA, anaemia show synergistic effect on hypertension

28 Mar 2025

Sacubitril-valsartan a boon to hypertension patients with ESKD on dialysis

27 Mar 2025

Treatment with sacubitril-valsartan (SV) demonstrates good tolerability and may provide some benefits to hypertension patients with end-stage kidney disease (ESKD) who are undergoing dialysis, as shown by the results of a recent meta-analysis.

Sacubitril-valsartan a boon to hypertension patients with ESKD on dialysis

27 Mar 2025

Sitting less, being more active can add years of life to postmenopausal cancer survivors

26 Mar 2025 by

New research suggests that increasing daily step count and engaging in physical activity while reducing sitting time may reduce the risk of death from all cause and from cardiovascular disease (CVD) among postmenopausal women with a history of cancer.

Sitting less, being more active can add years of life to postmenopausal cancer survivors

26 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16-31 March 2025)

Original New Drug Application Approvals by US FDA (16-31 March 2025)

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

Women more likely than men to receive high-intensity statins for secondary prevention post-CABG

Heart failure precedes rapid, sustained cognitive decline

Heart failure precedes rapid, sustained cognitive decline

What’s new in the 2025 ACS Guidelines?

What’s new in the 2025 ACS Guidelines?

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

Over-the-counter magnesium supplements help lower cardiovascular risk in diabetes

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

Fluoxetine boosts good cholesterol, lowers triglycerides in people with obesity

OSA, anaemia show synergistic effect on hypertension

OSA, anaemia show synergistic effect on hypertension

Sacubitril-valsartan a boon to hypertension patients with ESKD on dialysis

Sacubitril-valsartan a boon to hypertension patients with ESKD on dialysis

Sitting less, being more active can add years of life to postmenopausal cancer survivors

Sitting less, being more active can add years of life to postmenopausal cancer survivors